Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Children with leukemia treated with innovative CAR-T therapy
Children with leukemia treated with innovative CAR-T therapy
At the Princess Máxima Center children with B-cell acute lymphoblastic leukemia have been treated with 'CAR-T' cells for the first time. It's an innovative therapy in which our pediatric oncologists harvest T cells from the patient, alter them and then infuse the resulting CAR-T cells. These modified immune cells can then detect and destroy cancer cells. Pediatric oncologist Peter Hoogerbrugge of the Princess Máxima Center: "The first patients are home again."
Every year about 200 people in the Netherlands suffer from acute lymphoblastic leukemia (ALL). In most cases they are children aged 0 to 18 years.
CAR-T is currently only available for ALL. It may become available for many more forms of childhood cancer in the future.
